Xcout Intel
Relation Therapeutics Inc. competitors & alternatives
The 12 closest competitors and alternatives to Relation Therapeutics Inc. among biotech companies — ranked by similarity to what Relation Therapeutics Inc. actually does, not by market-cap band.
Subscribe to see Relation Therapeutics Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Relation Therapeutics Inc.
Relation Therapeutics Inc. is an active for-profit biotechnology company founded in 2019 that focuses on therapeutic development.
Relation Therapeutics Inc. at a glance
Relation Therapeutics Inc. is a biotech company headquartered in United States. It has raised at least $151.4M across the 6 funding rounds on record. Its most recent funding round raised $36.2M in November 2025. Xcout tracks 23 named people at Relation Therapeutics Inc., including David Roblin (Chief Executive Officer). Xcout recorded 16 job postings from Relation Therapeutics Inc. in the last 90 days, naming tools such as PyTorch, Jira.
Relation Therapeutics Inc. leadership
- David RoblinChief Executive Officer
- CASEY BENJAMIN SWERNERPresident
- Dave PowellPresident of Drug Discovery
- Rosie RodriguezPresident, Growth
- Benjamin SwernerChief Operating Officer
- Lindsay EdwardsChief Technology Officer
17 more named people on record for Relation Therapeutics Inc., with roles, board committees and tenure — see the full roster →
Relation Therapeutics Inc. funding rounds
At least $151.4M raised across the 6 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $36.2M | — | |
| SEC Form D filing | $15M | — | |
| Seed | $35M | 3 named | |
| Seed | $40.3M | 3 named | |
| SEC Form D filing | $16M | — | |
| SEC Form D filing | $9M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Hiring at Relation Therapeutics Inc.
Xcout recorded 16 job postings from Relation Therapeutics Inc. in the last 90 days, from a hiring record Xcout has kept since July 2026.
Tools named in Relation Therapeutics Inc.'s job postings
The weekly hiring trend, the roles and locations behind it — see Relation Therapeutics Inc.'s hiring signals →
Top 12 Relation Therapeutics Inc. competitors
Ranked by semantic similarity — how close each company is to Relation Therapeutics Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotech company
Cellarity is a U.S. biotechnology company that uses single-cell biology, computational modeling, and machine learning to discover medicines based on cellular behaviors and disease mechanisms. It serves pharmaceutical and biotechnology development needs, advancing its own therapeutic programs and potentially partnering with other drug developers.
Biotechnology
Modulus Therapeutics, Inc. is a research and development business services company located in Washington state, focusing on therapeutic innovations.
Similar biotech company
Metaphore Biotechnologies, Inc. is a biotechnology company headquartered in Cambridge, Massachusetts, operating as part of Flagship Pioneering. The company focuses on therapeutic design, leveraging AI and machine learning technologies for drug discovery and development.
Biotechnology
Genesis Therapeutics, Inc. is an active for-profit biotechnology company founded by Ben Sklaroff and Evan Feinberg. The company specializes in leveraging artificial intelligence for molecular discovery and drug development with operations in California and Delaware.
Similar biotech company
NeuroX1 Inc. is a for-profit biotechnology startup founded in 2021 with headquarters in Austin, Texas, operating a target identification and drug discovery platform that utilizes proprietary technology.
Healthtech
GATC Health Corp. is a biotechnology company that uses artificial intelligence, genomics, and toxicology data to discover and develop therapeutics and predict drug safety. Its work is aimed at pharmaceutical and biotechnology partners as well as patients needing treatments for serious diseases.
Similar biotech company
Rapport Therapeutics, Inc. functions as a clinical-phase biopharmaceutical enterprise, concentrating its efforts on discovering and developing innovative small-molecule therapeutics for individuals living with central nervous system (CNS) disorders. Its flagship product candidate, RAP-219, is an experimental small molecule precisely designed to inhibit TARPy8-containing AMPARs with exceptional potency (picomolar affinity). This promising compound aims to treat focal epilepsy and a range of other neurological conditions, including peripheral neuropathic pain and bipolar disorder. The company's pipeline further includes RAP-199, another molecule targeting TARPy8, which boasts distinct chemical and pharmacokinetic profiles. Moreover, Rapport is advancing several nicotinic acetylcholine receptor (nAChR) programs, such as an a6 nAChR therapy for chronic pain and an a9a10 nAChR treatment intended for hearing impairments. Formed in 2022 under the initial name Precision Neuroscience NewCo, Inc., the company adopted its current identity as Rapport Therapeutics, Inc. in October 2022, and its operations are based in Boston, Massachusetts.
Biotechnology
RenaissThera is a privately held biotechnology company headquartered in Bengaluru, India, dedicated to developing affordable, AI-powered small-molecule targeted therapies.
Biotechnology
Volnay Therapeutics LLC is a privately held biotechnology research and holding company incorporated in Delaware, United States. The company focuses on drug discovery pipelines and therapeutic research.
Similar biotech company
Ratio Therapeutics is a clinical-stage pharmaceutical company headquartered in Boston, Massachusetts. The company employs a suite of innovative technologies for the discovery and early clinical development of targeted radiopharmaceuticals.
Biotechnology
CHARM Therapeutics Inc. is a biopharmaceutical company utilizing proprietary technology platforms for drug discovery and therapeutic pipeline development.
Similar biotech company
Sharp Therapeutics Corp. is a preclinical-stage biotechnology and drug discovery company that develops small molecule therapies to treat genetic diseases and hereditary disorders. The company combines high-speed experimentation and computational methods to advance its drug discovery platform.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Relation Therapeutics Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Relation Therapeutics Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →